Related Experiment Videos
[Passive prophylactic immunisation against post-transfusion hepatitis by immunoglobulin preparations: a prospective
Deutsche Medizinische Wochenschrift (1946)
|October 1, 1982
Summary
Human immunoglobulin therapy significantly boosted hepatitis-B antibody levels in cardiac surgery patients, reducing infection rates. This treatment offers a promising protective strategy against viral infections post-surgery.
Area of Science:
- Immunology
- Virology
- Cardiovascular Surgery
Background:
- Cardiac surgery patients are susceptible to viral infections.
- Assessing immune response and infection rates is crucial post-cardiac surgery.
Purpose of the Study:
- To evaluate the efficacy of human immunoglobulin administration in preventing viral infections after cardiac surgery.
- To compare hepatitis-B virus (HBV) and cytomegalic virus (CMV) antibody responses between immunoglobulin-treated and control groups.
Main Methods:
- A randomized prospective study of 98 cardiac surgery patients.
- Treatment group (51 patients) received 20g intravenous human immunoglobulin over four months.
- Control group (47 patients) received standard blood transfusions (average 4.4 units).
Main Results:
- Hepatitis-B virus antibody prevalence increased from 43% to 94% in the immunoglobulin group, versus 43% in the control group.
- Hepatitis-B infections occurred in 2/51 patients in the immunoglobulin group compared to 10/47 in the control group.
- Antibody levels against cytomegalic virus increased in controls but not in the immunoglobulin group.
Conclusions:
- Human immunoglobulin therapy enhances hepatitis-B virus antibody response and reduces infection incidence in cardiac surgery patients.
- Immunoglobulin treatment may mitigate post-operative viral infections, including hepatitis-B.
- Further research is needed to understand the differential effects on CMV antibody responses.